In April 2026, Biogen announced that it would acquire exclusive rights to TJ Biopharma’s felzartamab in Greater China for up to $850m.
Biogen seeks Darzalex rivalry in China for multiple myeloma with felzartamab deal
In April 2026, Biogen announced that it would acquire exclusive rights to TJ Biopharma’s felzartamab in Greater China for up to $850m.
Chris and Xand continue their conversation with physiotherapist and vestibular rehabilitation specialist, Maggie Stacey.
These days you just have to wonder about the greed and corruption that is going on all around. Senator Dick Blumenthal is one of many who’ve …
آلام المفاصل شائعة، لكن الخرافات المحيطة بها أكثر شيوعًا لا يزال الكثيرون يعتقدون أن التهاب المفاصل مشكلة تصيب كبار السن فقط.
Acting Attorney General Todd Blanche said Sunday that the indictment of former FBI Director James Comey did not solely result from an Instagram post depicting seashells …